Attention Deficit Hyperactivity Disorder

AbbVie, Shire agree on $55B combination

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

Jul 18, 2014
popularity not rated yet | comments 0

Latest Spotlight News

A case for treating both mind and body

New research from Rutgers University lends more support to the idea that integrating treatment of mind and body could lead to better - and cheaper - medical care.